Wednesday, January 16, 2013

Funding approved for Alzheimer’s clinical trial


Long-awaited federal funding has been approved for a first-of-its-kind, Boston-­led study to test whether drugs can hold off Alzheimer’s disease in people who have no symptoms of the illness, but who have an abnormal protein in their brains believed to be a marker of the disease.

The National Institutes of Health announced Monday that the clinical trial, to be led by Dr. Reisa Sperling, an Alzheimer’s specialist at Brigham and ­Women’s Hospital, is one of four that will be funded this year to find treatments for the disease.

Jump to the Boston Globe for the details